High-throughput screening (HTS) using NMR spectroscopy has become a common component of the drug discovery effort and is widely used throughout the pharmaceutical industry. NMR provides additional information about the nature of small molecule-protein interactions compared to traditional HTS methods. In order to achieve comparable efficiency, small molecules are often screened as mixtures in NMR-based assays. Nevertheless, an analysis of the efficiency of mixtures and a corresponding determination of the optimum mixture size (OMS) that minimizes the amount of material and instrumentation time required for an NMR screen has been lacking. A model for calculating OMS based on the application of the hypergeometric distribution function to determine the probability of a 'hit' for various mixture sizes and hit rates is presented. An alternative method for the deconvolution of large screening mixtures is also discussed. These methods have been applied in a high-throughput NMR screening assay using a small, directed library.
Introduction
Traditional methods of screening targets against chemical libraries include cell-based assays, surrogate systems, and systems to measure nucleic acid-protein interactions and receptor-ligand interactions (Fernandes, 1998) . Libraries comprising hundreds of thousands of compounds can be screened in a short time period, where a particular robotic system has demonstrated a screening rate of 1,000 microtitre plates per 24 hours (Wallace, 1998) . Although an efficient means to screen very large chemical libraries for activity against a specific protein target, these traditional techniques generally provide no indication of the mechanism of inhibition or verification that a binding interaction between the target and ligand have actually occurred.
High-throughput screening (HTS) using nuclear magnetic resonance (NMR) spectroscopy has become a common component of the drug discovery effort and is widely used throughout the pharmaceutical industry because of the unique ability of NMR to provide direct evidence of a specific binding interaction between a potential chemical lead and the protein of interest (Klaus and Senn, 2003; Huth and Sun, 2002; Sem and Pellecchia, 2001; Roberts, 2000; Moore, 1999b; Moore, 1999a; Peng et al., 2001 ). Additionally, NMR may be used to evaluate the physical properties of a chemical lead, measure K D 's (Fielding, 2003) identify ligand binding sites (Roberts, 2000) , and determine a costructure (Clore and Gronenborn, 1994; Cooke, 1997; Kay, 1997; Roberts, 2000) . A diverse number of NMR screening approaches have been developed, which include SAR by NMR (Shuker et al., 1996; Hajduk et al., 1997a; Hajduk et al., 1997c; Hajduk et al., 1999b; Johnson et al., 2003) , SHAPES (Moore et al., 2004; Lepre et al., 2002; Fejzo et al., 1999) , and MS/NMR (Moy et al., 2001) . NMR spectroscopy is a relatively insensitive technique requiring higher amounts of material and acquisition time compared to standard methods used in traditional HTS assays. Thus, a fundamental issue with NMR screens is a need to optimize the efficiency of sample throughput by achieving a balance between information content and resource utilization. As a result, NMR-based assays utilize chemical libraries that are significantly smaller in size compared to the hundreds of thousands to millions of compounds typically screened in an HTS assay.
An approach used to address the fundamentally lower throughput of NMR has been the development of small, directed compound libraries that are more amenable to NMR-based screens (Huth and Sun, 2002; Jacoby et al., 2003; Baurin et al., 2004; Villar et al., 2004) . The SHAPES library is a typical example of the fragment based approach to NMR screening, where the library consists of a small, structurally diverse set of water soluble compounds that correspond to fragments or molecular frameworks of known drugs (Lin et al., 1997; Fejzo et al., 1999; Johnson et al., 2003; Lepre et al., 2002; Moore et al., 2004) . A comparable approach to reduce the size of screening libraries is to use NMR-based assays as a secondary screen to validate hits from HTS assays. In this manner, the HTS assays reduce a large corporate library to a small, focused list composed of a few hundred to a few thousands compounds that is more applicable to an NMR screen (Hajduk and Burns, 2002; Jahnke and Widmer, 2004) .
Since chemical libraries can still number in the thousands of compounds, even for directed libraries, mixtures of small molecules are often screened against a target to minimize resource utilization while increasing throughput (Jacoby et al., 2003; Chen and Shapiro, 1999; Lin et al., 1997; Meyer et al., 1997) . Screening mixtures of 5 to 100 compounds have been described where it may be feasible for an NMR assay to screen upwards of hundreds of thousands of compounds (Devlin et al., 1996; Glick et al., 2003; Hann et al., 1999; Jacoby et al., 2003; Pratt Steven et al., 2004; Hajduk et al., 1999a) . Thus, the use of mixtures makes an NMR assay readily amenable for screening smaller, directed libraries with the potential to screen larger, random libraries comparable to standard HTS assays.
There are some potential issues associated with the application of mixtures that impacts their wide-spread use in traditional HTS (Schriemer and Hindsgaul, 1998) . A major concern is the observation that mixtures increases the inherent 'noise' of an HTS assay by either increasing the occurrence of false positives or false negatives (Glick et al., 2004; Pratt Steven et al., 2004) . Another practical concern is the proper composition of the mixtures used for screening. Factors such as solubility, total organic concentration, structural diversity and compound reactivity may potentially limit the utility of mixtures in a screening endeavor (Brown et al., 2000; Brown and Martin, 1997; Schriemer and Hindsgaul, 1998; Hann et al., 1999) . It is particularly challenging to design appropriate mixtures that adhere to these needs, especially for larger library and mixture sizes (Brown and Martin, 1997; Glick et al., 2003) . Additionally, improvements in miniaturization and automation that continually improves the throughput of HTS assays diminishes any perceived advantage of mixtures (Dove and Marshall, 1999; Smith, 2002) .
Despite these limitations, compound mixtures are routinely used in NMR assays because of the significant advantage that is achieved in increasing throughput. In general, mixture sizes in NMR screens appear to be chosen rather arbitrarily, where the simple application of mixtures achieves the main goal of improved throughput. No significant consideration has been given to determine an optimal mixture size (OMS) for an efficient implementation of an NMR-based assay to minimize resources. Deconvolutions of mixtures to identify the active compound results in an increase in the total number of NMR experiments required to screen the entire library. The impact of the deconvolution step may overwhelm any advantages in efficiency gained by screening a specific mixture size compared to alternatives. Thus, the size of the mixture chosen for a particular screen directly determines the total number of NMR experiments that are required and establishes the efficiency of the assay. An increase in mixture size results in a proportional decrease in the number of primary NMR experiments. But, basic probability indicates that the likelihood of finding a hit and the need to deconvolute a mixture will also scale with an increase in mixture size. Furthermore, the total number of deconvolution
